As of Apr 29
| -0.26 / -4.43%|
The 2 analysts offering 12-month price forecasts for Osiris Therapeutics Inc have a median target of 11.25, with a high estimate of 18.50 and a low estimate of 4.00. The median estimate represents a +100.53% increase from the last price of 5.61.
The current consensus among 2 polled investment analysts is to Buy stock in Osiris Therapeutics Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.